Assess and Prioritize Agentic AI Use Cases in Pharmaceutical Manufacturing

Agentic AI adoption is limited by GxP exposure. AI that influences GxP-controlled processes is hard to deploy quickly without validation, auditability, and accountable human oversight.

CIOs cannot treat all digital knowledge as agent-ready. Agents need governed, current, version-controlled, and inspection-ready context, not just access to documents and systems.

Agentic AI exposes ownership gaps across the enterprise. No single function owns the full risk surface. CIOs need a governance model that clarifies who owns the agent, the data it uses, the decision it influences, the process it touches, and the evidence required to defend it.

Our Advice

Critical Insight

CIOs must make autonomy earn its place in pharma. Every agent that touches regulated work needs a defined decision role, approved knowledge sources, validated behavior, audit-ready evidence, and a named owner for the outcome; only then will agentic AI become scalable, defensible, and trusted.

Impact and Result

Classify agentic AI opportunities. Each use case should be classified by GxP exposure, decision criticality, autonomy level, and required evidence.
Define boundaries before selecting use cases. Each autonomy level should have clear rules for human review, auditability, validation, exception handling, and escalation.
Build an agent-ready knowledge foundation. CIOs must ensure that data sources are current, version-controlled, permission-aware, and semantically connected through master data and process taxonomies.

Assess and Prioritize Agentic AI Use Cases in Pharmaceutical Manufacturing Research & Tools

1. Assess and Prioritize Agentic AI Use Cases in Pharmaceutical Manufacturing Storyboard – A step-by-step document that helps CIOs and pharmaceuticals manufacturing leaders understand where agentic AI can unlock new operating capabilities.

Identify high-value opportunities for agentic AI by connecting pharmaceutical business priorities to the regulated operational capabilities required for governed autonomy. To move from AI experimentation to responsible agentic AI adoption, pharmaceutical manufacturers must understand where agents can create meaningful value, what regulated decisions they can safely assist, recommend, coordinate, or execute, and what data, process, integration, validation, security, and governance foundations are needed before autonomy can scale.

This storyboard will help you understand the capabilities and opportunities of agentic AI in pharmaceutical manufacturing, assess where agents can sense, reason, coordinate, and act across Plan, Source, Make, Deliver, Quality, Regulatory, and Commercial operations, evaluate use cases against business value, compliance exposure, and operational readiness, and build a practical roadmap for responsible adoption. It will also help you define the controls, decision rights, audit trails, human oversight, and accountability structures required to ensure agentic AI improves speed and performance without weakening quality, compliance, patient safety, or trust.

2. Agentic AI Use Case Tool for Pharmaceutical Manufacturing – A structured tool to help pharmaceutical manufacturing leaders prioritize agentic AI opportunities and build a roadmap for responsible adoption.

This tool guides pharmaceutical manufacturing leaders through the evaluation and prioritization activities required to build a practical agentic AI adoption roadmap. This Excel workbook helps you connect business goals to agentic AI opportunities, assess where autonomous or semi-autonomous capabilities can create measurable value, and determine which use cases are most appropriate to pursue first across discovery & development, clinical trials & regulatory reviews, commercial manufacturing, sales, marketing and customer support.

Build a controlled path from decision support to bounded autonomy across the pharmaceutical manufacturing value chain.

About Info-Tech

Info-Tech Research Group is the world’s fastest-growing information technology research and advisory company, proudly serving over 30,000 IT professionals.

We produce unbiased and highly relevant research to help CIOs and IT leaders make strategic, timely, and well-informed decisions. We partner closely with IT teams to provide everything they need, from actionable tools to analyst guidance, ensuring they deliver measurable results for their organizations.

What Is a Blueprint?

A blueprint is designed to be a roadmap, containing a methodology and the tools and templates you need to solve your IT problems.

Each blueprint can be accompanied by a Guided Implementation that provides you access to our world-class analysts to help you get through the project.

Need Extra Help?
Speak With An Analyst

Get the help you need in this 5-phase advisory process. You'll receive multiple touchpoints with our researchers, all included in your membership.

Guided Implementation 1: Establish familiarity

Call 1: Review the capability map/value stream map.
Call 2: Identify domains where agentic AI may create value.

Guided Implementation 2: Understand criteria

Call 1: Understand agentic AI use cases across value stream domains.
Call 2: Define the decision boundaries and expected operational outcomes.

Guided Implementation 3: Evaluate use cases

Call 1: Evaluate fitment & risk scenarios.

Guided Implementation 4: Define value

Call 1: Estimate value for each use case using metrics.

Guided Implementation 5: Prioritize deployment

Call 1: Prioritize use cases by balancing value, risk, and readiness.
Call 2: Develop a sequenced adoption roadmap.

Author

Shreyas Shukla

Contributors

Tim Smart, IT Director, Global Pharmaceuticals Company
Steven Schmidt, Sr. Managing Partner, Info-Tech Research Group
1 Anonymous Contributor